Cardiovascular Endocrinology and Metabolism

SJR Rank #11,616H-index: 22SJR: 0.512Best quartile: Q2Open AccessListed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Lippincott Williams and Wilkins

Country

United States

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Cardiology and Cardiovascular MedicineQ2
  • Endocrinology, Diabetes and MetabolismQ3

Areas: Medicine

Most published research topics

Diabetes Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic DiseasesCOVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patientsLipoproteins and Cardiovascular HealthCardiovascular Disease and AdiposityDiet and metabolism studies

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs015304560

Documents per Year

2022202506121824

Detailed Information

ISSN

2574-0954

SJR Best Quartile

Q2

Region

Northern America

Citations per Document (2 years)

1.33

References per Document

35.52

Coverage

2018-2025

Scope

Cardiovascular Endocrinology & Metabolism publishes peer-reviewed research in vascular disease, endocrinology, diabetes and metabolism. Particular emphasis is placed on studies that illuminate the interaction between these disciplines and foster effective collaboration between cardiologists, endocrinologists and diabetologists. The journal serves as a single resource for research and clinical communities specialising in cardiology, endocrinology, diabetology, and metabolism. High quality state-of-the-art reviews, invited editorials, and expert commentaries place original articles in context at the interface of basic and clinical research.

Metrics from SCImago Journal Rank 2025. View on SCImago